96 related articles for article (PubMed ID: 30265376)
1. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
[TBL] [Abstract][Full Text] [Related]
2. ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Nastały P; Filipska M; Morrissey C; Eltze E; Semjonow A; Brandt B; Pantel K; Bednarz-Knoll N
Transl Res; 2019 Jan; 203():49-56. PubMed ID: 30287243
[TBL] [Abstract][Full Text] [Related]
3. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.
Madjd Z; Ramezani B; Molanae S; Asadi-Lari M
Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
5. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
6. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Bednarz-Knoll N; Nastały P; Żaczek A; Stoupiec MG; Riethdorf S; Wikman H; Müller V; Skokowski J; Szade J; Sejda A; Wełnicka-Jaśkiewicz M; Pantel K
Oncotarget; 2015 Sep; 6(29):26789-803. PubMed ID: 26305673
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
9. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Saruwatari K; Ikemura S; Sekihara K; Kuwata T; Fujii S; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Ochiai A; Kohrogi H; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2016 Jan; 91():7-14. PubMed ID: 26711928
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.
Bednarz N; Eltze E; Semjonow A; Rink M; Andreas A; Mulder L; Hannemann J; Fisch M; Pantel K; Weier HU; Bielawski KP; Brandt B
Clin Cancer Res; 2010 Jul; 16(13):3340-8. PubMed ID: 20592016
[TBL] [Abstract][Full Text] [Related]
11. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
Heerma van Voss MR; van der Groep P; Bart J; van der Wall E; van Diest PJ
Cell Oncol (Dordr); 2011 Feb; 34(1):3-10. PubMed ID: 21336637
[TBL] [Abstract][Full Text] [Related]
12. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
13. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
14. mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
Finetti F; Terzuoli E; Giachetti A; Santi R; Villari D; Hanaka H; Radmark O; Ziche M; Donnini S
Endocr Relat Cancer; 2015 Aug; 22(4):665-78. PubMed ID: 26113609
[TBL] [Abstract][Full Text] [Related]
15. [Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
Zhao Y; Jin X; Li N; Zhu B; Qian J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 47(1):54-9. PubMed ID: 27062782
[TBL] [Abstract][Full Text] [Related]
16. [Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Zhao Y; Jin X; Li N; Li J; Qian J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1390-1395. PubMed ID: 27777204
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.
DA Cruz Paula A; Marques O; Sampaio R; Rosa A; Garcia J; Rêma A; DE Fátima Faria M; Silva P; Vizcaíno R; Lopes C
Anticancer Res; 2016 Sep; 36(9):4629-38. PubMed ID: 27630305
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Ruscito I; Darb-Esfahani S; Kulbe H; Bellati F; Zizzari IG; Rahimi Koshkaki H; Napoletano C; Caserta D; Rughetti A; Kessler M; Sehouli J; Nuti M; Braicu EI
Gynecol Oncol; 2018 Jul; 150(1):151-157. PubMed ID: 29753392
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Matsika A; Srinivasan B; Day C; Mader SA; Kiernan DM; Broomfield A; Fu J; Hooper JD; Kench JG; Samaratunga H
Pathology; 2015 Dec; 47(7):622-8. PubMed ID: 26517640
[TBL] [Abstract][Full Text] [Related]
20. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]